APA

Janelidze S., Stomrud E., Smith R., Palmqvist S., Mattsson N., Airey D. C., Proctor N. K., Chai X., Shcherbinin S., Sims J. R., Triana-Baltzer G., Theunis C., Slemmon R., Mercken M., Kolb H., Dage J. L. & Hansson O. (20200731). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. : Nature communications.

Chicago

Janelidze Shorena, Stomrud Erik, Smith Ruben, Palmqvist Sebastian, Mattsson Niklas, Airey David C, Proctor Nicholas K, Chai Xiyun, Shcherbinin Sergey, Sims John R, Triana-Baltzer Gallen, Theunis Clara, Slemmon Randy, Mercken Marc, Kolb Hartmuth, Dage Jeffrey L and Hansson Oskar. 20200731. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. : Nature communications.

Harvard

Janelidze S., Stomrud E., Smith R., Palmqvist S., Mattsson N., Airey D. C., Proctor N. K., Chai X., Shcherbinin S., Sims J. R., Triana-Baltzer G., Theunis C., Slemmon R., Mercken M., Kolb H., Dage J. L. and Hansson O. (20200731). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. : Nature communications.

MLA

Janelidze Shorena, Stomrud Erik, Smith Ruben, Palmqvist Sebastian, Mattsson Niklas, Airey David C, Proctor Nicholas K, Chai Xiyun, Shcherbinin Sergey, Sims John R, Triana-Baltzer Gallen, Theunis Clara, Slemmon Randy, Mercken Marc, Kolb Hartmuth, Dage Jeffrey L and Hansson Oskar. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. : Nature communications. 20200731.